On the other hand, a recent paper by Rodrigo et al. [16] uncovered a novel role for NANOG in the early stages of laryngeal tumorigenesis, and more importantly, its clinical application as a biomarker for cancer risk assessment in patients with laryngeal precancerous lesions. Here, NANOG is linked to cancer.